ORTHOPEDIATRICS CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $37.3m $45.6m $57.6m $72.6m $71.1m $98.0m $122.3m $148.7m $204.7m $236.3m
Cost of Revenue $10.9m $11.2m $14.9m $17.9m $16.0m $24.6m $31.6m $37.5m $56.1m $63.7m
Gross Profit $26.4m $34.5m $42.7m $54.6m $55.0m $73.4m $90.7m $111.3m $148.6m $172.7m
Operating Expenses $32.5m $40.9m $52.2m $63.7m $81.8m $91.4m $116.1m $138.0m $183.6m $211.9m
Operating Income (Loss) ($6.1m) ($6.5m) ($9.6m) ($9.1m) ($26.8m) ($18.0m) ($25.4m) ($26.8m) ($35.0m) ($39.2m)
Additional Financial Items
Amortization of Intangible Assets $35k $246k $378k $887k $3.2m $4.5m $6.0m $7.1m $7.8m $8.2m
Goodwill, Impairment Loss $0 $0 $0 $1.9m
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($12.0m) ($28.8m) ($9.2m) $6.5m ($12.6m) ($27.3m) ($37.1m)
Income (Loss) from Continuing Operations, Per Basic Share ($7.14) ($5.86) ($0.96) ($1) ($2) ($1) $0 ($1) ($2) ($2)
Income (Loss) from Continuing Operations, Per Diluted Share ($7.14) ($5.86) ($0.96) ($1) ($2) ($1) $0 ($1) ($2) ($2)
Realized Investment Gains (Losses) ($1.6m) ($1.4m) $119k $32k
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $12.7m $33.7m ($17.4m) ($3.7m) ($21.3m) ($41.9m) ($39.2m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($6.6m) ($8.9m) ($12.0m) ($12.7m) ($32.9m) ($16.3m) $1.3m ($21.0m) ($37.8m) ($39.6m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($16.3m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $0 $0 ($1.0m) $0 $0
Net Income (Loss) Attributable to Parent ($6.6m) ($8.9m) ($12.0m) ($13.7m) ($32.9m) ($16.3m) $1.3m ($21.0m) ($37.8m) ($39.6m)
Net Income (Loss) Available to Common Stockholders, Basic ($12.4m) ($23.5m) ($12.0m) ($13.7m) ($32.9m) $1.2m ($21.0m) ($37.8m) ($39.6m)
Earnings Per Share, Basic ($7.14) ($5.86) ($0.96) ($0.94) ($1.82) ($0.84) $0.06 ($0.92) ($1.64) ($1.69)
Earnings Per Share, Diluted ($7.14) ($5.86) ($0.96) ($0.94) ($1.82) ($0.84) $0.06 ($0.92) ($1.64) ($1.69)
Weighted Average Number of Shares Outstanding, Basic 19.3m 20.7m 22.7m 23.1m 23.5m
Weighted Average Number of Shares Outstanding, Diluted 19.3m 20.9m 22.7m 23.1m 23.5m
Research and Development Expense $2.2m $3.4m $4.7m $5.7m $5.3m $5.5m $8.0m $10.2m $11.0m $9.1m
General and Administrative Expense $11.6m $17.0m $20.9m $26.7m $38.3m $46.1m $59.4m $75.4m $102.8m $119.8m
Other Nonoperating Income (Expense) $1.0m $30k ($217k) ($70k) $20k $1.1m ($1.8m) $2.3m ($1.1m) $6.0m
Interest Expense (non-operating) $2.6m $6.0m
Business Combination, Acquisition Related Costs $737k
Current Income Tax Expense (Benefit) $0 $0 $723k $1.1m $85k $825k $629k $613k
Interest Expense $1.5m $2.5m $2.3m $3.5m $3.4m
Interest Expense, Debt $42k $35k $27k
Selling and Marketing Expense $16.7m $20.5m $26.6m $31.3m $31.9m $39.7m $45.1m $51.4m $64.3m $72.7m
Income Tax Expense (Benefit) $0 $0 $0 $0 ($723k) ($1.1m) ($4.9m) ($338k) ($4.1m) $460k
Interest Income (Expense), Net ($2.2m) ($2.4m) $198k $2.6m $6.0m